$371 Million is the total value of SECTOR GAMMA AS's 33 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 48.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | Buy | LILLY ELI & CO | $41,052,000 | +12.6% | 804,947 | +11.1% | 11.08% | +18.4% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $31,189,000 | +4.1% | 2,594,800 | +1.7% | 8.42% | +9.5% |
| FRX | Sell | FOREST LABS INC | $26,434,000 | -23.3% | 440,349 | -45.3% | 7.13% | -19.4% |
| BAX | Buy | BAXTER INTL INC | $24,176,000 | +20.9% | 347,600 | +14.2% | 6.52% | +27.2% |
| CAH | Sell | CARDINAL HEALTH INC | $19,756,000 | -3.3% | 295,700 | -24.5% | 5.33% | +1.7% |
| JNJ | Sell | JOHNSON & JOHNSON | $18,918,000 | -40.2% | 206,550 | -43.4% | 5.10% | -37.1% |
| A | Buy | AGILENT TECHNOLOGIES INC | $16,185,000 | +13.8% | 283,000 | +2.0% | 4.37% | +19.7% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $14,270,000 | +13.9% | 217,000 | +20.6% | 3.85% | +19.7% |
| CBST | Sell | CUBIST PHARMACEUTICALS INC | $12,127,000 | -6.5% | 176,090 | -13.7% | 3.27% | -1.7% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $11,932,000 | +20.0% | 297,700 | +13.1% | 3.22% | +26.1% |
| PKI | Buy | PERKINELMER INC | $11,675,000 | +17.3% | 283,160 | +7.4% | 3.15% | +23.3% |
| LPNT | Buy | LIFEPOINT HOSPITALS INC | $11,413,000 | +30.6% | 216,000 | +15.3% | 3.08% | +37.3% |
| MDCO | Sell | MEDICINES CO | $11,117,000 | +4.2% | 287,850 | -9.6% | 3.00% | +9.5% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $10,670,000 | +75.3% | 141,700 | +66.7% | 2.88% | +84.3% |
| ESRX | Buy | EXPRESS SCRIPTS INC | $10,311,000 | +36.2% | 146,800 | +19.8% | 2.78% | +43.3% |
| THOR | Buy | THORATEC CORP | $9,886,000 | +15.3% | 270,100 | +17.4% | 2.67% | +21.2% |
| AUXL | Sell | AUXILIUM PHARMACEUTICALS INC | $9,588,000 | -30.9% | 462,504 | -39.3% | 2.59% | -27.3% |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $8,615,000 | +72.0% | 741,991 | +75.4% | 2.32% | +80.9% |
| DGX | New | QUEST DIAGNOSTICS INC | $8,198,000 | – | 153,128 | +100.0% | 2.21% | – |
| BIO | Buy | BIO RAD LABS INCcl a | $7,194,000 | +13.7% | 58,200 | +8.2% | 1.94% | +19.6% |
| RMD | New | RESMED INC | $7,109,000 | – | 151,000 | +100.0% | 1.92% | – |
| MASI | Sell | MASIMO CORP | $7,107,000 | -29.0% | 243,150 | -35.3% | 1.92% | -25.4% |
| STJ | New | ST JUDE MED INC | $6,567,000 | – | 106,000 | +100.0% | 1.77% | – |
| BIIB | New | BIOGEN IDEC INC | $5,591,000 | – | 20,000 | +100.0% | 1.51% | – |
| AGN | Sell | ALLERGAN INC | $4,999,000 | -18.6% | 45,000 | -33.7% | 1.35% | -14.4% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $4,400,000 | +52.8% | 38,910 | +6.6% | 1.19% | +60.6% |
| HNT | New | HEALTH NET INC | $4,302,000 | – | 145,000 | +100.0% | 1.16% | – |
| IART | New | INTEGRA LIFESCIENCES HLDGS C | $3,387,000 | – | 71,000 | +100.0% | 0.91% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $3,358,000 | – | 115,000 | +100.0% | 0.91% | – |
| THC | New | TENET HEALTHCARE CORP | $3,327,000 | – | 79,000 | +100.0% | 0.90% | – |
| OMI | Sell | OWENS & MINOR INC NEW | $2,928,000 | -33.3% | 80,084 | -36.9% | 0.79% | -29.9% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $2,419,000 | -10.0% | 136,800 | -26.8% | 0.65% | -5.4% |
| SPPI | SPECTRUM PHARMACEUTICALS INC | $443,000 | +5.7% | 50,000 | 0.0% | 0.12% | +11.1% | |
| HSP | Exit | HOSPIRA INC | $0 | – | -76,000 | -100.0% | -0.76% | – |
| OPTR | Exit | OPTIMER PHARMACEUTICALS INC | $0 | – | -376,393 | -100.0% | -1.22% | – |
| 5100PS | Exit | VOLCANO CORPORATION | $0 | – | -312,700 | -100.0% | -1.92% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -179,000 | -100.0% | -2.02% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -105,800 | -100.0% | -2.06% | – |
| SLXP | Exit | SALIX PHARMACEUTICALS INC | $0 | – | -141,301 | -100.0% | -2.42% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -148,900 | -100.0% | -2.66% | – |
| ONXX | Exit | ONYX PHARMACEUTICALS INC | $0 | – | -103,215 | -100.0% | -3.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.